0001209191-17-049764.txt : 20170821
0001209191-17-049764.hdr.sgml : 20170821
20170821212116
ACCESSION NUMBER: 0001209191-17-049764
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170817
FILED AS OF DATE: 20170821
DATE AS OF CHANGE: 20170821
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KINGSLEY ALFRED D
CENTRAL INDEX KEY: 0001229339
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-12830
FILM NUMBER: 171044047
MAIL ADDRESS:
STREET 1: 150 E 57TH STREET
CITY: NEW YORK
STATE: NY
ZIP: 10022
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOTIME INC
CENTRAL INDEX KEY: 0000876343
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 943127919
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1010 ATLANTIC AVENUE
STREET 2: SUITE 102
CITY: ALAMEDA
STATE: CA
ZIP: 94501
BUSINESS PHONE: 5105213390
MAIL ADDRESS:
STREET 1: 1010 ATLANTIC AVENUE
STREET 2: SUITE 102
CITY: ALAMEDA
STATE: CA
ZIP: 94501
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-08-17
0
0000876343
BIOTIME INC
BTX
0001229339
KINGSLEY ALFRED D
150 E. 57TH STREET
NEW YORK
NY
10022
1
1
0
0
See Remarks
Common Shares, no par value
2017-08-17
4
D
0
300000
2.81
D
5481555
D
Common Shares, no par value
1143346
I
By Greenbelt Corp.
Common Shares, no par value
375351
I
By Greenway Partners, LP
On August 17, 2017, Mr. Kingsley exchanged 300,000 BioTime common shares for 421,500 common shares of AgeX Therapeutics, Inc., a subsidiary of BioTime.
Does not include shares that Mr. Kingsley may acquire through the exercise of certain options.
Mr. Kingsley is Chairman of certain BioTime subsidiaries.
/s/Alfred D. Kingsley
2017-08-21